Skip to content

Effect of the Consumption of Alcohol-free Beers With Different Carbohydrates Composition on Postprandial Metabolic Response

Effect of the Consumption of Alcohol-free Beers With Different Carbohydrates Composition on Postprandial Metabolic Response

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04790877
Enrollment
30
Registered
2021-03-10
Start date
2020-02-01
Completion date
2021-03-30
Last updated
2021-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Diet, Postprandial Hyperglycemia

Keywords

Carbohydrates, Alcohol-free beer, Maltodextrin, Isomaltulose

Brief summary

The overall objective of this study is to explore the glycemic index and glycemic load induced by an alcohol-free beer with modified composition (including almost full fermentation of carbohydrates and the addition of isomaltulose and a resistant maltodextrin), as well as its postprandial metabolic response, compared to the effect induced by: a) an alcohol-free beer with a usual composition; b) an alcohol-free beer with modified composition (including almost full fermentation of carbohydrates and the addition of a resistant maltodextrin). This study includes two cross-over sub-studies recruiting healthy participants. In the first one, 10 healthy volunteers receive 25 g of carbohydrates coming from: regular alcohol-free beer (RB), alcohol-free beer with almost completely eliminated maltose and enriched with isomaltulose (2.5 g/100 mL) and a resistant maltodextrin (0.8 g/100 mL) (IMB), alcohol-free beer with the same maltose removal enriched with resistant maltodextrin (2.0 g/100 mL) (MB) and glucose solution. In the second study, 20 healthy volunteers are provided with 50 g of carbohydrates from white bread and water and the same meal plus 14.3 g of carbohydrates coming from: RB, IMB, MB and extra white bread. Blood is sampled at baseline and for 2 h, every 15 min, after ingestion.

Interventions

OTHERSub-study 1

Subjects were provided with: a) Glucose beverage; b) Regular alcohol-free beer; c) Alcohol-free beer with modified composition (isomaltulose + maltodextrin); d) Alcohol-free beer with modified composition (++ maltodextrin).

OTHERSub-study 2

Subjects were provided with: a) White bread + Water; b) White bread + Regular alcohol-free beer; c) White bread+Alcohol-free beer enriched with isomaltulose+maltodextrin); d) White bread + Alcohol-free beer enriched with ++ maltodextrin; e) Extra-White bread + Water.

Sponsors

Instituto de Salud Carlos III
CollaboratorOTHER_GOV
Universidad de Zaragoza
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Masking description

The investigator who prepares the beverages and the bread is not blinded but the investigator who manage the samples and is plan to analyze the results is blinded.

Intervention model description

The overall study involved two sub-studies. The first one includes 4 arms and the second one includes 5 arms.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI between 18.5 and 27.5 kg/m2.

Exclusion criteria

* Presence of cardiometabolic pathology such as dyslipemia (total cholesterol \> 200 mg/dL and/or triglycerides \> 150 mg/dL, and/or taking lipid-lowering drugs), prediabetes or type 1 or 2 diabetes mellitus (glucose ≥ 100 mg/dL and/or glycosylated hemoglobin ≥ 5.7% and/or taking hypoglycemic drugs) or high blood pressure without drug treatment. * Presence of other chronic pathologies that could interfere with the results of the study such as cardiovascular disease, kidney disease, thyroid disease or liver disease. * Presence of intestinal malabsorption syndromes and/or presence of Chron disease or ulcerative colitis. * Use of drugs that may interfere with lipid and/or glycidic metabolism. * Presence of some analytical alteration that could interfere with the results of the study. * Increased or decreased body weight of ≥ 5 kg in the last 6 months. * Gluten intolerance. * Regular intake of functional foods such as phytosterols or red rice yeast, which have a significant effect on lipid or glycidic metabolism, in the last 6 weeks. * Intake of vitamin supplements. * Hormone replacement therapy.

Design outcomes

Primary

MeasureTime frame
GIPChange from Baseline to 15-minutes after consumption of the beverage.
GlucoseChange from Baseline to 15-minutes after consumption of the beverage.
InsulinChange from Baseline to 15-minutes after consumption of the beverage.
GLP-1Change from Baseline to 15-minutes after consumption of the beverage.

Secondary

MeasureTime frame
Pancreatic polypeptideChange from Baseline to 60-minutes after consumption of the beverage.
HDL cholesterolChange from Baseline to 60-minutes after consumption of the beverage.
LeptinChange from Baseline to 60-minutes after consumption of the beverage.
TriglyceridesChange from Baseline to 60-minutes after consumption of the beverage.
LDL cholesterolChange from Baseline to 60-minutes after consumption of the beverage.
GlucagonChange from Baseline to 60-minutes after consumption of the beverage.
GhrelinChange from Baseline to 60-minutes after consumption of the beverage.
Polypeptide YChange from Baseline to 60-minutes after consumption of the beverage.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026